Cactus Botanics Announces Low Molecular Weight Hyaluronic Acid For Food and Cosmetic Industries

Cactus Botanics Announces Low Molecular Weight Hyaluronic Acid For Food and Cosmetic Industries Company introduces low molecular weight hyaluronic acid.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Beneo(TM)Synergy1, breakthrough bone health claims Latest research at the Children’s Nutrition Research Center, Baylor College of Medicine, Houston, Texas, has not only shown that Beneo™Synergy1 increases calcium uptake, but also concluded that the extra-absorbed calcium is going exactly where it is needed - straight to the bones. One hundred adolescents were given either 8g Beneo(TM)Synergy1 or an equivalent amount of placebo every day for a year, and after one year, the increase in Bone Mineral Density (BMD) among the Beneo(TM)Synergy1 group was 45% higher compared to the controls, with bone mineral content showing 30mg bone calcium accretion per day. Beneo(TM)Synergy1, breakthrough bone health claims Latest research at the Children’s Nutrition Research Center, Baylor College of Medicine, Houston, Texas, has not only shown that Beneo™Synergy1 increases calcium uptake, but also concluded that the extra-absorbed calcium is going exactly where it is needed - straight to the bones. One hundred adolescents were given either 8g Beneo(TM)Synergy1 or an equivalent amount of placebo every day for a year, and after one year, the increase in Bone Mineral Density (BMD) among the Beneo(TM)Synergy1 group was 45% higher compared to the controls, with bone mineral content showing 30mg bone calcium accretion per day. Beneo(TM)Synergy1, breakthrough bone health claims Latest research at the Children’s Nutrition Research Center, Baylor College of Medicine, Houston, Texas, has not only shown that Beneo™Synergy1 increases calcium uptake, but also concluded that the extra-absorbed calcium is going exactly where it is needed - straight to the bones. One hundred adolescents were given either 8g Beneo(TM)Synergy1 or an equivalent amount of placebo every day for a year, and after one year, the increase in Bone Mineral Density (BMD) among the Beneo(TM)Synergy1 group was 45% higher compared to the controls, with bone mineral content showing 30mg bone calcium accretion per day. AgroLabs Introduces Acai Extreme Energy Formula at Costco AgroLabs, Inc., a wholly- owned subsidiary of Integrated BioPharma, Inc. has announced that Costco will be selling AgroLabs' proprietary Acai Extreme Energy product at more than 300 Costco wholesale stores throughout the United States beginning June 1, 2006. AgroLabs Introduces Acai Extreme Energy Formula at Costco AgroLabs, Inc., a wholly- owned subsidiary of Integrated BioPharma, Inc. has announced that Costco will be selling AgroLabs' proprietary Acai Extreme Energy product at more than 300 Costco wholesale stores throughout the United States beginning June 1, 2006. AgroLabs Introduces Acai Extreme Energy Formula at Costco AgroLabs, Inc., a wholly- owned subsidiary of Integrated BioPharma, Inc. has announced that Costco will be selling AgroLabs' proprietary Acai Extreme Energy product at more than 300 Costco wholesale stores throughout the United States beginning June 1, 2006. AgroLabs Introduces Acai Extreme Energy Formula at Costco AgroLabs, Inc., a wholly- owned subsidiary of Integrated BioPharma, Inc. has announced that Costco will be selling AgroLabs' proprietary Acai Extreme Energy product at more than 300 Costco wholesale stores throughout the United States beginning June 1, 2006. AgroLabs Introduces Acai Extreme Energy Formula at Costco AgroLabs, Inc., a wholly- owned subsidiary of Integrated BioPharma, Inc. has announced that Costco will be selling AgroLabs' proprietary Acai Extreme Energy product at more than 300 Costco wholesale stores throughout the United States beginning June 1, 2006. Horse Chestnut Gets the Nod from Prevention Magazine Company's horse chestnut supplement, Venaforce, was featured in the “Alternatives: Natural Healer” department of the June issue of Prevention magazine. Horse Chestnut Gets the Nod from Prevention Magazine Company's horse chestnut supplement, Venaforce, was featured in the “Alternatives: Natural Healer” department of the June issue of Prevention magazine. Horse Chestnut Gets the Nod from Prevention Magazine Company's horse chestnut supplement, Venaforce, was featured in the “Alternatives: Natural Healer” department of the June issue of Prevention magazine. Horse Chestnut Gets the Nod from Prevention Magazine Company's horse chestnut supplement, Venaforce, was featured in the “Alternatives: Natural Healer” department of the June issue of Prevention magazine. Protient Introduces Domestic Micellar Casein Company introduces Micellar Casein (Protient 5202) that contains 92% micellar casein obtained through a proprietary process from domestic skim milk. Protient Introduces Domestic Micellar Casein Company introduces Micellar Casein (Protient 5202) that contains 92% micellar casein obtained through a proprietary process from domestic skim milk. Protient Introduces Domestic Micellar Casein Company introduces Micellar Casein (Protient 5202) that contains 92% micellar casein obtained through a proprietary process from domestic skim milk. Protient Introduces Domestic Micellar Casein Company introduces Micellar Casein (Protient 5202) that contains 92% micellar casein obtained through a proprietary process from domestic skim milk. Protient Introduces Domestic Micellar Casein Company introduces Micellar Casein (Protient 5202) that contains 92% micellar casein obtained through a proprietary process from domestic skim milk. Treatt Brings Out the Best In Blueberries Company has introduced Blueberry Treattarome™ 9840 to its expanding range of 100% natural, FTNF (From The Named Food) flavor ingredients, wholly distilled from top grade, freshly cultivated berries. Treatt Brings Out the Best In Blueberries Company has introduced Blueberry Treattarome™ 9840 to its expanding range of 100% natural, FTNF (From The Named Food) flavor ingredients, wholly distilled from top grade, freshly cultivated berries. Treatt Brings Out the Best In Blueberries Company has introduced Blueberry Treattarome™ 9840 to its expanding range of 100% natural, FTNF (From The Named Food) flavor ingredients, wholly distilled from top grade, freshly cultivated berries. Treatt Brings Out the Best In Blueberries Company has introduced Blueberry Treattarome™ 9840 to its expanding range of 100% natural, FTNF (From The Named Food) flavor ingredients, wholly distilled from top grade, freshly cultivated berries. Treatt Brings Out the Best In Blueberries Company has introduced Blueberry Treattarome™ 9840 to its expanding range of 100% natural, FTNF (From The Named Food) flavor ingredients, wholly distilled from top grade, freshly cultivated berries. Treatt Brings Out the Best In Blueberries Company has introduced Blueberry Treattarome™ 9840 to its expanding range of 100% natural, FTNF (From The Named Food) flavor ingredients, wholly distilled from top grade, freshly cultivated berries. Treatt Brings Out the Best In Blueberries Company has introduced Blueberry Treattarome™ 9840 to its expanding range of 100% natural, FTNF (From The Named Food) flavor ingredients, wholly distilled from top grade, freshly cultivated berries. Treatt Brings Out the Best In Blueberries Company has introduced Blueberry Treattarome™ 9840 to its expanding range of 100% natural, FTNF (From The Named Food) flavor ingredients, wholly distilled from top grade, freshly cultivated berries. Treatt Brings Out the Best In Blueberries Company has introduced Blueberry Treattarome™ 9840 to its expanding range of 100% natural, FTNF (From The Named Food) flavor ingredients, wholly distilled from top grade, freshly cultivated berries. Treatt Brings Out the Best In Blueberries Company has introduced Blueberry Treattarome™ 9840 to its expanding range of 100% natural, FTNF (From The Named Food) flavor ingredients, wholly distilled from top grade, freshly cultivated berries. Treatt Brings Out the Best In Blueberries Company has introduced Blueberry Treattarome™ 9840 to its expanding range of 100% natural, FTNF (From The Named Food) flavor ingredients, wholly distilled from top grade, freshly cultivated berries. BioVittoria's PureLo® Luo Han Fruit-Based Sweetener Obtains GRAS Affirmation PureLo®, the company's proprietary Luo Han fruit concentrate, has been affirmed as a GRAS (Generally Regarded As Safe) food ingredient enabling its use in a variety of foods and beverages as a sweetener and flavor modifier. BioVittoria's PureLo® Luo Han Fruit-Based Sweetener Obtains GRAS Affirmation PureLo®, the company's proprietary Luo Han fruit concentrate, has been affirmed as a GRAS (Generally Regarded As Safe) food ingredient enabling its use in a variety of foods and beverages as a sweetener and flavor modifier. BioVittoria's PureLo® Luo Han Fruit-Based Sweetener Obtains GRAS Affirmation PureLo®, the company's proprietary Luo Han fruit concentrate, has been affirmed as a GRAS (Generally Regarded As Safe) food ingredient enabling its use in a variety of foods and beverages as a sweetener and flavor modifier. BioVittoria's PureLo® Luo Han Fruit-Based Sweetener Obtains GRAS Affirmation PureLo®, the company's proprietary Luo Han fruit concentrate, has been affirmed as a GRAS (Generally Regarded As Safe) food ingredient enabling its use in a variety of foods and beverages as a sweetener and flavor modifier. BioVittoria's PureLo® Luo Han Fruit-Based Sweetener Obtains GRAS Affirmation PureLo®, the company's proprietary Luo Han fruit concentrate, has been affirmed as a GRAS (Generally Regarded As Safe) food ingredient enabling its use in a variety of foods and beverages as a sweetener and flavor modifier. BioVittoria's PureLo® Luo Han Fruit-Based Sweetener Obtains GRAS Affirmation PureLo®, the company's proprietary Luo Han fruit concentrate, has been affirmed as a GRAS (Generally Regarded As Safe) food ingredient enabling its use in a variety of foods and beverages as a sweetener and flavor modifier. BioVittoria's PureLo® Luo Han Fruit-Based Sweetener Obtains GRAS Affirmation PureLo®, the company's proprietary Luo Han fruit concentrate, has been affirmed as a GRAS (Generally Regarded As Safe) food ingredient enabling its use in a variety of foods and beverages as a sweetener and flavor modifier. Omega-3 Partnership Between Fjordlaks and Borregaard Fjordlaks and Borregaard have entered into a long-term strategic agreement for Omega-3 oils, under which Fjordlaks will deliver high quality crude fish oils which will be refined and marketed by Borregaard’s wholly owned subsidiary, Denomega Nutritional Oils. Omega-3 Partnership Between Fjordlaks and Borregaard Fjordlaks and Borregaard have entered into a long-term strategic agreement for Omega-3 oils, under which Fjordlaks will deliver high quality crude fish oils which will be refined and marketed by Borregaard’s wholly owned subsidiary, Denomega Nutritional Oils. Omega-3 Partnership Between Fjordlaks and Borregaard Fjordlaks and Borregaard have entered into a long-term strategic agreement for Omega-3 oils, under which Fjordlaks will deliver high quality crude fish oils which will be refined and marketed by Borregaard’s wholly owned subsidiary, Denomega Nutritional Oils. Omega-3 Partnership Between Fjordlaks and Borregaard Fjordlaks and Borregaard have entered into a long-term strategic agreement for Omega-3 oils, under which Fjordlaks will deliver high quality crude fish oils which will be refined and marketed by Borregaard’s wholly owned subsidiary, Denomega Nutritional Oils. Omega-3 Partnership Between Fjordlaks and Borregaard Fjordlaks and Borregaard have entered into a long-term strategic agreement for Omega-3 oils, under which Fjordlaks will deliver high quality crude fish oils which will be refined and marketed by Borregaard’s wholly owned subsidiary, Denomega Nutritional Oils. Omega-3 Partnership Between Fjordlaks and Borregaard Fjordlaks and Borregaard have entered into a long-term strategic agreement for Omega-3 oils, under which Fjordlaks will deliver high quality crude fish oils which will be refined and marketed by Borregaard’s wholly owned subsidiary, Denomega Nutritional Oils. Omega-3 Partnership Between Fjordlaks and Borregaard Fjordlaks and Borregaard have entered into a long-term strategic agreement for Omega-3 oils, under which Fjordlaks will deliver high quality crude fish oils which will be refined and marketed by Borregaard’s wholly owned subsidiary, Denomega Nutritional Oils. Omega-3 Partnership Between Fjordlaks and Borregaard Fjordlaks and Borregaard have entered into a long-term strategic agreement for Omega-3 oils, under which Fjordlaks will deliver high quality crude fish oils which will be refined and marketed by Borregaard’s wholly owned subsidiary, Denomega Nutritional Oils. Omega-3 Partnership Between Fjordlaks and Borregaard Fjordlaks and Borregaard have entered into a long-term strategic agreement for Omega-3 oils, under which Fjordlaks will deliver high quality crude fish oils which will be refined and marketed by Borregaard’s wholly owned subsidiary, Denomega Nutritional Oils. Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology. Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology. Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology. Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology. Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology. Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology. Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology. Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology. Next Pharmaceuticals Announces New Delivery Form for Relora® Company announces that a microencapsulated concentrate version of the ingredient Relora® is now available. Next Pharmaceuticals Announces New Delivery Form for Relora® Company announces that a microencapsulated concentrate version of the ingredient Relora® is now available. Next Pharmaceuticals Announces New Delivery Form for Relora® Company announces that a microencapsulated concentrate version of the ingredient Relora® is now available. Next Pharmaceuticals Announces New Delivery Form for Relora® Company announces that a microencapsulated concentrate version of the ingredient Relora® is now available. Next Pharmaceuticals Announces New Delivery Form for Relora® Company announces that a microencapsulated concentrate version of the ingredient Relora® is now available. Next Pharmaceuticals Announces New Delivery Form for Relora® Company announces that a microencapsulated concentrate version of the ingredient Relora® is now available. EuroPharma Appointed Exclusive US Distributor of New Omega-3 With Biological Absorption Level Higher than Other Fish Oils EuroPharma has entered into an exclusive North American distribution agreement for Vectomega®, a natural marine complex made up of five different phospholipids, DHA and EPA, along with proteins and amino acids as they occur in nature. EuroPharma Appointed Exclusive US Distributor of New Omega-3 With Biological Absorption Level Higher than Other Fish Oils EuroPharma has entered into an exclusive North American distribution agreement for Vectomega®, a natural marine complex made up of five different phospholipids, DHA and EPA, along with proteins and amino acids as they occur in nature. EuroPharma Appointed Exclusive US Distributor of New Omega-3 With Biological Absorption Level Higher than Other Fish Oils EuroPharma has entered into an exclusive North American distribution agreement for Vectomega®, a natural marine complex made up of five different phospholipids, DHA and EPA, along with proteins and amino acids as they occur in nature. EuroPharma Appointed Exclusive US Distributor of New Omega-3 With Biological Absorption Level Higher than Other Fish Oils EuroPharma has entered into an exclusive North American distribution agreement for Vectomega®, a natural marine complex made up of five different phospholipids, DHA and EPA, along with proteins and amino acids as they occur in nature. EuroPharma Appointed Exclusive US Distributor of New Omega-3 With Biological Absorption Level Higher than Other Fish Oils EuroPharma has entered into an exclusive North American distribution agreement for Vectomega®, a natural marine complex made up of five different phospholipids, DHA and EPA, along with proteins and amino acids as they occur in nature. EuroPharma Appointed Exclusive US Distributor of New Omega-3 With Biological Absorption Level Higher than Other Fish Oils EuroPharma has entered into an exclusive North American distribution agreement for Vectomega®, a natural marine complex made up of five different phospholipids, DHA and EPA, along with proteins and amino acids as they occur in nature. EuroPharma Appointed Exclusive US Distributor of New Omega-3 With Biological Absorption Level Higher than Other Fish Oils EuroPharma has entered into an exclusive North American distribution agreement for Vectomega®, a natural marine complex made up of five different phospholipids, DHA and EPA, along with proteins and amino acids as they occur in nature. Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals General Nutrition Centers, Inc. Reports FY09 Q3 Results General Nutrition Centers, Inc., has announced their FY09 Q3 results, reporting consolidated revenues of $430.8 million, an increase of 4.0% over the consolidated revenues of $414.2 million for the same quarter of 2008. Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health Bayer Consumer Care has announced the launch of their new Citracal(R) Calcium plus Heart Health for bone and heart care. Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health Bayer Consumer Care has announced the launch of their new Citracal(R) Calcium plus Heart Health for bone and heart care. Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health Bayer Consumer Care has announced the launch of their new Citracal(R) Calcium plus Heart Health for bone and heart care. Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health Bayer Consumer Care has announced the launch of their new Citracal(R) Calcium plus Heart Health for bone and heart care. Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health Bayer Consumer Care has announced the launch of their new Citracal(R) Calcium plus Heart Health for bone and heart care. Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health Bayer Consumer Care has announced the launch of their new Citracal(R) Calcium plus Heart Health for bone and heart care. Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health Bayer Consumer Care has announced the launch of their new Citracal(R) Calcium plus Heart Health for bone and heart care. Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health Bayer Consumer Care has announced the launch of their new Citracal(R) Calcium plus Heart Health for bone and heart care. Senomyx Announces Corporate Update and FY09 Q3 Results Senomyx, Inc., has announced their FY09 Q3 results, reporting revenues were $4.2 million for the third quarter of 2009, compared to $4.0 million for the third quarter of 2008, an increase of 3%. Senomyx Announces Corporate Update and FY09 Q3 Results Senomyx, Inc., has announced their FY09 Q3 results, reporting revenues were $4.2 million for the third quarter of 2009, compared to $4.0 million for the third quarter of 2008, an increase of 3%. Senomyx Announces Corporate Update and FY09 Q3 Results Senomyx, Inc., has announced their FY09 Q3 results, reporting revenues were $4.2 million for the third quarter of 2009, compared to $4.0 million for the third quarter of 2008, an increase of 3%. GLG Life Tech Corporation Announces Receipt of Demand Letter GLG Life Tech Corporation has announced that it has received a demand letter from Weider Global Nutrition that states that WGN will commence, on November 4, 2009, legal proceedings in the Supreme Court of British Columbia against the Company. GLG Life Tech Corporation Announces Receipt of Demand Letter GLG Life Tech Corporation has announced that it has received a demand letter from Weider Global Nutrition that states that WGN will commence, on November 4, 2009, legal proceedings in the Supreme Court of British Columbia against the Company. GLG Life Tech Corporation Announces Receipt of Demand Letter GLG Life Tech Corporation has announced that it has received a demand letter from Weider Global Nutrition that states that WGN will commence, on November 4, 2009, legal proceedings in the Supreme Court of British Columbia against the Company. GLG Life Tech Corporation Announces Receipt of Demand Letter GLG Life Tech Corporation has announced that it has received a demand letter from Weider Global Nutrition that states that WGN will commence, on November 4, 2009, legal proceedings in the Supreme Court of British Columbia against the Company. GLG Life Tech Corporation Announces Receipt of Demand Letter GLG Life Tech Corporation has announced that it has received a demand letter from Weider Global Nutrition that states that WGN will commence, on November 4, 2009, legal proceedings in the Supreme Court of British Columbia against the Company. Ingredients Manufacturer Goes Small Taura Natural Ingredients has announced their new Mini Fruit Bits. Ingredients Manufacturer Goes Small Taura Natural Ingredients has announced their new Mini Fruit Bits. Ingredients Manufacturer Goes Small Taura Natural Ingredients has announced their new Mini Fruit Bits. Ingredients Manufacturer Goes Small Taura Natural Ingredients has announced their new Mini Fruit Bits. Ingredients Manufacturer Goes Small Taura Natural Ingredients has announced their new Mini Fruit Bits. Ingredients Manufacturer Goes Small Taura Natural Ingredients has announced their new Mini Fruit Bits. Ingredients Manufacturer Goes Small Taura Natural Ingredients has announced their new Mini Fruit Bits. MGP Ingredients, Inc. Announces FY10 Q1 Results MGP Ingredients, Inc., has announced their FY10 Q1 results, reporting net income of $3,738,000, or $0.22 in diluted earnings per share, for the first quarter of fiscal 2010, which ended September 30, 2009. This compares with a net loss of $17,243,000, or $1.04 in diluted loss per share, for the first quarter of fiscal 2009. The increase in earnings was primarily the result of an improved sales mix of value-added products, reductions in grain and energy costs, and lower payroll costs as a result of restructuring completed in fiscal year 2009. MGP Ingredients, Inc. Announces FY10 Q1 Results MGP Ingredients, Inc., has announced their FY10 Q1 results, reporting net income of $3,738,000, or $0.22 in diluted earnings per share, for the first quarter of fiscal 2010, which ended September 30, 2009. This compares with a net loss of $17,243,000, or $1.04 in diluted loss per share, for the first quarter of fiscal 2009. The increase in earnings was primarily the result of an improved sales mix of value-added products, reductions in grain and energy costs, and lower payroll costs as a result of restructuring completed in fiscal year 2009. MGP Ingredients, Inc. Announces FY10 Q1 Results MGP Ingredients, Inc., has announced their FY10 Q1 results, reporting net income of $3,738,000, or $0.22 in diluted earnings per share, for the first quarter of fiscal 2010, which ended September 30, 2009. This compares with a net loss of $17,243,000, or $1.04 in diluted loss per share, for the first quarter of fiscal 2009. The increase in earnings was primarily the result of an improved sales mix of value-added products, reductions in grain and energy costs, and lower payroll costs as a result of restructuring completed in fiscal year 2009. Whole Foods Market Reports FY09 Q4 Results Whole Foods Market, Inc., has announced their FY09 Q4 results, reporting sale for the quarter increased 2.3% to $1.8 billion. Comparable store sales decreased 0.9% versus a 0.4% increase in the prior year. Identical store sales, excluding eight relocations and two major expansions, decreased 2.3% versus a 0.5% decrease in the prior year. Excluding the negative impact of foreign currency translation, comparable store sales decreased 0.7%, and identical store sales decreased 2.0%. Whole Foods Market Reports FY09 Q4 Results Whole Foods Market, Inc., has announced their FY09 Q4 results, reporting sale for the quarter increased 2.3% to $1.8 billion. Comparable store sales decreased 0.9% versus a 0.4% increase in the prior year. Identical store sales, excluding eight relocations and two major expansions, decreased 2.3% versus a 0.5% decrease in the prior year. Excluding the negative impact of foreign currency translation, comparable store sales decreased 0.7%, and identical store sales decreased 2.0%. Whole Foods Market Reports FY09 Q4 Results Whole Foods Market, Inc., has announced their FY09 Q4 results, reporting sale for the quarter increased 2.3% to $1.8 billion. Comparable store sales decreased 0.9% versus a 0.4% increase in the prior year. Identical store sales, excluding eight relocations and two major expansions, decreased 2.3% versus a 0.5% decrease in the prior year. Excluding the negative impact of foreign currency translation, comparable store sales decreased 0.7%, and identical store sales decreased 2.0%. New Study Shows Vitamin C with Metabolites Reduces Oxalate Levels Compared to Ascorbic Acid KGK Synergize Inc., has announced study results published in Urologic Nursing, which identify a significant change in 24-hour urine oxalate levels among two treatments. The study was conducted as a randomized, double-blind, crossover trial of vitamin C with metabolites (Ester-C®) compared to ascorbic acid in 50 healthy adults. New Study Shows Vitamin C with Metabolites Reduces Oxalate Levels Compared to Ascorbic Acid KGK Synergize Inc., has announced study results published in Urologic Nursing, which identify a significant change in 24-hour urine oxalate levels among two treatments. The study was conducted as a randomized, double-blind, crossover trial of vitamin C with metabolites (Ester-C®) compared to ascorbic acid in 50 healthy adults. New Study Shows Vitamin C with Metabolites Reduces Oxalate Levels Compared to Ascorbic Acid KGK Synergize Inc., has announced study results published in Urologic Nursing, which identify a significant change in 24-hour urine oxalate levels among two treatments. The study was conducted as a randomized, double-blind, crossover trial of vitamin C with metabolites (Ester-C®) compared to ascorbic acid in 50 healthy adults. NPI Daily - Top of The News for Nov. 5, 2009 - Natural Products Foundation Dinner at SSW - Meet John Gay Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health; Nutrition 21 Announces FY10 Q1 Results; General Nutrition Centers, Inc. Reports FY09 Q3 Results; Senomyx Announces Corporate Update and FY09 Q3 Results; Canaccord Capital Inc. Reports FY10 Q2 results; MGP Ingredients, Inc. Announces FY10 Q1 Results; Whole Foods Market Reports FY09 Q4 Results; CP Kelco Begins Production at New Facility and Introduces MAJOL(R) CMC; Herbalife Opens New Markets in Vietnam and Paraguay; CRN Welcomes Five New Voting Members to the Association; CRN Announces Date, Location for The Workshop and The Conference, 2010; Natural Products Foundation 2009 SupplySide West Networking Dinner - Meet the New Executive Director and CEO of the Natural Products Association; New Study Shows Vitamin C with Metabolites Reduces Oxalate Levels Compared to Ascorbic Acid; BioSecur Lab Receives NOP/USDA and ECOCERT Organic Certifications for BIOSECUR™ Product Line; GLG Life Tech Corporation Announces Receipt of Demand Letter; OmniActive Health Technologies Launches Eye Health Ingredient; Smart Balance Announces Nationwide Milk Rollout; Navitas Naturals Adds Organic Cacao Paste to Line of Raw Cacao Products; derma e® Receives Editor's Pick Awards; Nordic Naturals Professional Exclusive Division Introduces Prenatal DHA; Chr. Hansen Launches New Animal Health and Nutrition Website; Natural Remedies Launches GutGard™ Web Site; Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health; Ingredients Manufacturer Goes Small; The BENEO-Group Confirms How Ice Cream Can Be Both Healthy and Indulgent; Jeffrey Dunn Joins Herbalife Board NPI Daily - Top of The News for Nov. 5, 2009 - Natural Products Foundation Dinner at SSW - Meet John Gay Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health; Nutrition 21 Announces FY10 Q1 Results; General Nutrition Centers, Inc. Reports FY09 Q3 Results; Senomyx Announces Corporate Update and FY09 Q3 Results; Canaccord Capital Inc. Reports FY10 Q2 results; MGP Ingredients, Inc. Announces FY10 Q1 Results; Whole Foods Market Reports FY09 Q4 Results; CP Kelco Begins Production at New Facility and Introduces MAJOL(R) CMC; Herbalife Opens New Markets in Vietnam and Paraguay; CRN Welcomes Five New Voting Members to the Association; CRN Announces Date, Location for The Workshop and The Conference, 2010; Natural Products Foundation 2009 SupplySide West Networking Dinner - Meet the New Executive Director and CEO of the Natural Products Association; New Study Shows Vitamin C with Metabolites Reduces Oxalate Levels Compared to Ascorbic Acid; BioSecur Lab Receives NOP/USDA and ECOCERT Organic Certifications for BIOSECUR™ Product Line; GLG Life Tech Corporation Announces Receipt of Demand Letter; OmniActive Health Technologies Launches Eye Health Ingredient; Smart Balance Announces Nationwide Milk Rollout; Navitas Naturals Adds Organic Cacao Paste to Line of Raw Cacao Products; derma e® Receives Editor's Pick Awards; Nordic Naturals Professional Exclusive Division Introduces Prenatal DHA; Chr. Hansen Launches New Animal Health and Nutrition Website; Natural Remedies Launches GutGard™ Web Site; Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health; Ingredients Manufacturer Goes Small; The BENEO-Group Confirms How Ice Cream Can Be Both Healthy and Indulgent; Jeffrey Dunn Joins Herbalife Board	Hyaluronic Acid, sometimes abbreviated as HA, is present in every tissue of the body, including the synovial joint fluid, the vitreous humor of the eye, cartilage, blood vessels, extracellular matrix, skin and the umbilical cord. Retention of water is one of the most important biological functions of hyaluronic acid, second only to providing nutrients and removing waste from cells that do not have a direct blood supply, such as cartilage cells. When a lower than adequate amount of hyaluronic acid is present, nutrients cannot be moved into these cells and waste cannot be eliminated. High molecular weight substances are not easily absorbed by the body. This too is the case with hyaluronic acid. Therefore, the lower the molecular weight of the Hyaluronic Acid, the better its absorbtion will be. However, making as low as possible a molecular weight Hyaluronic Acid is a technological challenge for many manufacturers. Cactus Botanics' manufacturing operation has invested in the development of technology to manufacture low molecular weight Hyaluronic Acid, currently producing product with a lowest molecular weight of about 5 thousand. The company is also able to provide higher molecular weight Hyaluronic Acid for those requiring it. Visit http://www.cactusbotanics.com/Hyaluronic%20Acid.htm for the Hyaluronic Acid data sheet. Please feel free to contact us at info@cactusbotanics.com for more information.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software